Increased expression of IRF8 in tumor cells inhibits the generation of Th17 cells and predicts unfavorable survival of diffuse large B cell lymphoma patients.

about

Rituximab or irradiation promotes IL-17 secretion and thereby induces resistance to rituximab or irradiation.Increased interleukin-17A levels promote rituximab resistance by suppressing p53 expression and predict an unfavorable prognosis in patients with diffuse large B cell lymphoma.

P2860

Q49900929-18E5D224-FF26-492A-915F-0AA5314F760A Q52670077-5F4A5A82-CE84-46CA-8531-15A7F009893F

P2860

Increased expression of IRF8 in tumor cells inhibits the generation of Th17 cells and predicts unfavorable survival of diffuse large B cell lymphoma patients.

Item

http://www.wikidata.org/entity/Q41472727

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Increased expression of IRF8 i ...... arge B cell lymphoma patients.

@en

type

Item

label

Increased expression of IRF8 i ...... arge B cell lymphoma patients.

@en

prefLabel

Increased expression of IRF8 i ...... arge B cell lymphoma patients.

@en

P1476

Increased expression of IRF8 i ...... arge B cell lymphoma patients.

@en

P2093

Hong Du

http://www.w3.org/2001/XMLSchema#string

Huabao Xiong

http://www.w3.org/2001/XMLSchema#string

Li Yang

http://www.w3.org/2001/XMLSchema#string

Qinghua Du

http://www.w3.org/2001/XMLSchema#string

Qingshan Li

http://www.w3.org/2001/XMLSchema#string

Weijie Zhong

http://www.w3.org/2001/XMLSchema#string

Xin Xu

http://www.w3.org/2001/XMLSchema#string

Yanying Ling

http://www.w3.org/2001/XMLSchema#string

Zhigang Zhu

http://www.w3.org/2001/XMLSchema#string

P2860

Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene

Transcription factor IRF8 directs a silencing programme for TH17 cell differentiation

DNA methylation represses IFN-gamma-induced and signal transducer and activator of transcription 1-mediated IFN regulatory factor 8 activation in colon carcinoma cells

CD70+ non-Hodgkin lymphoma B cells induce Foxp3 expression and regulatory function in intratumoral CD4+CD25 T cells

The role and regulation of human Th17 cells in tumor immunity

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells

Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma

IFN regulatory factor 8 mediates apoptosis in nonhemopoietic tumor cells via regulation of Fas expression

P304

49757-49772

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.17693

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28537908

http://www.w3.org/2001/XMLSchema#string

P932

5564805

http://www.w3.org/2001/XMLSchema#string

Increased expression of IRF8 in tumor cells inhibits the generation of Th17 cells and predicts unfavorable survival of diffuse large B cell lymphoma patients.

about

P2860

P2860

Increased expression of IRF8 in tumor cells inhibits the generation of Th17 cells and predicts unfavorable survival of diffuse large B cell lymphoma patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932